Term
Local Anesthetics Definition |
|
Definition
Drug that produces reversible conduction blockade of impulses along centeral and peripheral nerve pathways |
|
|
Term
|
Definition
Cocaine
Procaine (ester)
Lidocaine (amide)- intense and longer acting |
|
|
Term
|
Definition
Autonomic--> Sensory--> Motor |
|
|
Term
|
Definition
Axon
Must bind to Na Channels inside of the cell |
|
|
Term
|
Definition
Surround each individual nerve |
|
|
Term
|
Definition
Surround each individual nerve fascile |
|
|
Term
|
Definition
Encases groups of fasicles into a sheath |
|
|
Term
|
Definition
jump from one node of ranvier to another
Takes 2-3 Nodes for LA to take effect |
|
|
Term
|
Definition
Temperature (Cold before hot)--> Pain--> Touch--> Deep pressure |
|
|
Term
|
Definition
Motor--> Sensory--> Autonomic |
|
|
Term
LA Affect on RMP and Threshold |
|
Definition
Does NOT alter resting membrane potential or threshold potential |
|
|
Term
|
Definition
Vasoconstriction at low doses
Vasodilation at clinically relevant doses |
|
|
Term
|
Definition
The lower the systemic absorption, the higher the safety profile
Dose is direct linear relationships of absorption-not drug concentration or speed of injection
Highly lipid soluble have prolonged effects because they are stuck in fat |
|
|
Term
Injections to High Vascular Areas |
|
Definition
IV > Tracheal > Intercostal > Caudal > Paracervical > Epidural > Brachial > Subarachnoid > Sciatic > Femoral > Subcutaneous |
|
|
Term
|
Definition
Metbolized by rapid hydrolysis by psuedocholinesterases
Have PABA metbolites that can cause allergic reaction
Have one i in the name |
|
|
Term
|
Definition
Can cause methemoglobinemia
No Baby-Orajel |
|
|
Term
|
Definition
Metabolized by CYP450 enzymes in the liver
Have two I in the name
Prilocaine > lidocaine > Mepivicaine > Ropivicaine > Bupivicaine (rate of metabolism) |
|
|
Term
|
Definition
Caused by prilocaine, lidocaine, and benzocaine
Fe3+ which cannot carry O2
Treatment is methylene blue 1-2mg/kg over 5m in |
|
|
Term
|
Definition
Minimum concentration of LA necessary to produce conduction blockade
Cm of motor fibers is 2x that of sensory fibers that why you have differential blockade |
|
|
Term
|
Definition
LA are weak bases
Unionized form cross the lipid membrane and then becomes ionized
Ionized form binds to the intracellular sodium channel at the H gate during inactivated-closed state prevent Na+ from going through the channel and causing an action potential |
|
|
Term
|
Definition
Directly related to Lipid solubility= more lipid soluble the more potent
Closely related to protein binding= more lipid soluble the more protein bound and the longer duration of action |
|
|
Term
|
Definition
Hydrogen, ion balance
Fiber size, type, and myleination
Vasodilation/Vasoconstrictor properties
Frequency of stimulation of the nerve
pH
Electrolyte concentrations (hypokalemia and hypercalcemia antagonized blockade) |
|
|
Term
Which enantiomer are safer in Racemic mixtures of LA? |
|
Definition
S enantiomer
Ropivacaine and Levobupivacaine are pure S enantiomers
Most LA are racemic |
|
|
Term
|
Definition
Direct relationship to onset of LA
If the pKa of a LA is closer to physiologic pH then it will have a more rapid onset
This is because the ionized portion and unionized portion are in a closer ratio
Lidocaine, mepivacaine, prilocaine, and etidocaine have a pka ~7.6-7.8
Ropivacaine and bupivicaine have a pKa~8.1-8.6 so they have a longer onset |
|
|
Term
Exception to pKa rule of onset |
|
Definition
Chloroprocaine
Has a high pKa and rapid onset
Think it might be due to the high clinical dose we use
|
|
|
Term
Commerical Prepartion of LA |
|
Definition
Poorly water soluble
Acidic prepartions
Can alkalinze the solution to make a faster onset- makes more LA available in unionzed form
May cause precipitation |
|
|
Term
|
Definition
Weak bases
Aromatic ring- essentential in making the LA lipophilic
Tertiary amine group
Amide or ester connenction |
|
|
Term
|
Definition
LA incorporated into liposome
Prolongs duration and decreases toxicity
Slow release formulation
Exparel- liposomal bupivacaine |
|
|
Term
|
Definition
Vasoconstrictor
Prolongs LA block by decreasing systemic absorption
5mcg/ml or 1:200,000
Should never be injected into end arteries (ears, nose, penis, fingers) |
|
|
Term
|
Definition
Opioids and clonidine
Work synergistically
Longer, more intense blockade
Clonidine can improve duration of analgesia by 2 hrs |
|
|
Term
|
Definition
Beware of Ion trapping- fetal pH is usually lower than moms, unionized form crosses placenta but then gets stuck there
Hormonal changes dilate epidural veins so dose should be reduced by 30% reguardless of trimester
Have reduced plasmaesterase- keep in mind with esters- prolonged block |
|
|
Term
|
Definition
3 mg/kg max dose
Highly lipid soluble and potent with longer duration of action
0.25% bupivacaine dose should be equally to how many kg pt is
Ex. 10 kg pt, 10 ml is max |
|
|
Term
|
Definition
4 mg/ kg
Lidocaine with epi is 7 mg/ kg |
|
|
Term
Allergic Reactions to LAs |
|
Definition
Usually caused by PABA metabolite of esters
Allergy to ester does not mean allergy to amide
Sometimes it's the preservatives (methylparaban) |
|
|
Term
|
Definition
Most commonly from accidential IV injection during epidural or PNB
Aspirate before you injection
Usually see signs immediately up to 20 mins
neurotoxic signs before cardiac signs |
|
|
Term
|
Definition
|
|
Term
|
Definition
Numbness
Tinnitus
Muscle Twitching
Systemic Hypotension
Myocardial depression |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Cardiovascular depression |
|
|
Term
Transient Neurologic Symptoms |
|
Definition
Moderate to Severe pain in lower back, buttocks, and posterior thighs
Occurs within 6-36 hr after single shot spinal
Recovery usually within 1-7 days
Usaully from intrathecal lidocaine- NO LIDOCAINE spinals |
|
|
Term
|
Definition
Diffuse injury across the lumbosacral plexus
Have sensory anesthesia, bowel and bladder dysfunction, and paraplegia
Usually lidocaine- no lidocaine spinals |
|
|
Term
Anterior Spinal Artery Syndrome |
|
Definition
Lower extremity paresis with variable sensory deficit thats diagnosed as neural blockade resolves
Possibly from thrombosis or spasm of the anterior spinal artery |
|
|
Term
|
Definition
Precipitous hypotension, cardiac dysrhythmias, AV heart block
Resuscitation resistant- need fat emulsion (Intralipid)
LA does not have enough time to dissociate during diastole
May be precipitated by beta blockers, dig, calcium channel blockers |
|
|
Term
Intralipid Dosing for Bupivacaine Toxcitity |
|
Definition
20 % lipid emulsion
1.5 mL/kg over 3 mins
IV infusion of 15 mL/kg/hr |
|
|
Term
|
Definition
Can cause bronchoconstriction in asthmatics |
|
|
Term
|
Definition
Topical
Local Infiltration
Aerolized for Fiberoptic Intubation
Peripheral Nerve Blocks
IV regional (Bier Block)
Spinal
Epidural |
|
|
Term
|
Definition
Diffuse from the outer surface toward the center
Therfore fibers that are more proximal becomes anesthetized first then distal |
|
|
Term
|
Definition
Extremity isolated from rest of the systemic circulation by tourniquet
Duration determined by how long tourniquet is inflated
NO BUPIVACAINE |
|
|
Term
|
Definition
Subcutaneous infiltration of large volumes of solution with diluted lidocaine
Provides local anesthesia, bloodless aspirates, and postop analgesia
Slow release of Lidocaine into the circulation that peaks in 12-24 hours
High risk of mortality |
|
|
Term
Max Dose for Tumescent Lidocaine |
|
Definition
|
|
Term
Atypical Psuedocholinesterase |
|
Definition
Usually genetic
Will have a dibucaine # < 20
This means that if you give them Succinylcholine they will have apean and paraylsis lasting 2 hours or longer |
|
|
Term
|
Definition
70 is normal
40-70 will have a mimimally prolonged effect
<20 will have apnea and paralysis for 2 hours or longer |
|
|
Term
Acquired Conditions Affecting Pseudocholinesterase |
|
Definition
Liver Disease
Renal Disease
Malnutrition
Pregnancy
Malignancy
Burns
Cardiopulmonary Bypass
(pseudocholinesterase are synthesized in the liver) |
|
|
Term
|
Definition
Can cause methemoglobinemia
NO FDA warning on labels
Look for signs of hypoxia
Do not give to children under 2 years |
|
|